SCHEMBL793954

SCHEMBL793954

CC(C)=CCC/C(C)=C/Cc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.56
PPARG P37231 1/20 0.56
PPARA Q07869 1/20 0.56
MAPT P10636 2/20 0.52
PGR P06401 1/20 0.52
HTR1A P08908 1/20 0.52
ADORA3 P0DMS8 1/20 0.52
PTGS1 P23219 1/20 0.52
PDE4A P27815 1/20 0.52
MAPK1 P28482 1/20 0.52
DRD3 P35462 1/20 0.52
SNCA P37840 1/20 0.52
PDE3A Q14432 1/20 0.52
KMT2A Q03164 2/20 0.52
CNR2 P34972 1/20 0.51
VKORC1 Q9BQB6 1/20 0.49
PTPN1 P18031 1/20 0.49
BACE1 P56817 1/20 0.49
CYP3A4 P08684 2/20 0.48
MEN1 O00255 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31670205 1.00 TRPV1 (0.56) TRPV1PPARGPPARAMAPTPGR
SCHEMBL9953748 1.00 TRPV1 (0.56) TRPV1PPARGPPARAMAPTPGR
SCHEMBL17867387 0.98 KMT2A (0.55) TRPV1PPARGPPARAMAPTPGR
SCHEMBL17867386 0.98 KMT2A (0.55) TRPV1PPARGPPARAMAPTPGR
SCHEMBL4996440 0.87 PPARG (0.49) TRPV1PPARGPPARAMAPTPGR
SCHEMBL3088505 0.84 TRPV1 (0.62) TRPV1PPARGPPARAMAPTPGR
SCHEMBL14695430 0.84 TRPV1 (0.62) TRPV1PPARGPPARAMAPTPGR
SCHEMBL3099921 0.84 TRPV1 (0.62) TRPV1PPARGPPARAMAPTPGR
SCHEMBL19664772 0.84 PPARG (0.58) TRPV1PPARGPPARAMAPTKMT2A
SCHEMBL2072104 0.84 KMT2A (0.52) PPARGPPARAMAPTPGRHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4223749-B1 PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS DEYI PHARMACEUTICAL LTD (CN) 2025-08-06 EP claimed
CN-117491535-B Quality evaluation method of external gel bulk drug of lindera root 山东省食品药品检验研究院 2024-03-22 CN claimed
CN-117491535-A Quality evaluation method of external gel bulk drug of lindera root 山东省食品药品检验研究院 2024-02-02 CN claimed
US-20230406834-A1 PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS DEYI PHARMACEUTICAL LTD. (CN) 2023-12-21 US claimed
EP-4223749-A1 PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS Deyi Pharmaceutical Ltd. (CN) 2023-08-09 EP claimed
WO-2022099931-A1 PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS 德义制药有限公司 2022-05-19 WO claimed
CN-113501801-B Lindane type sesquiterpene geranyl benzene polymer and preparation method and application thereof 山东省食品药品检验研究院 2021-11-26 CN claimed
CN-113501801-A Lindane type sesquiterpene geranyl benzene polymer and preparation method and application thereof 山东省食品药品检验研究院 2021-10-15 CN claimed
EP-4223749-B1 PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS DEYI PHARMACEUTICAL LTD (CN) 2025-08-06 EP disclosed
CN-117491535-B Quality evaluation method of external gel bulk drug of lindera root 山东省食品药品检验研究院 2024-03-22 CN disclosed
CN-117491535-A Quality evaluation method of external gel bulk drug of lindera root 山东省食品药品检验研究院 2024-02-02 CN disclosed
US-20230406834-A1 PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS DEYI PHARMACEUTICAL LTD. (CN) 2023-12-21 US disclosed
US-20230406834-A1 PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS DEYI PHARMACEUTICAL LTD. (CN) 2023-12-21 US disclosed
EP-4223749-A1 PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS Deyi Pharmaceutical Ltd. (CN) 2023-08-09 EP disclosed
CN-113501801-A Lindane type sesquiterpene geranyl benzene polymer and preparation method and application thereof 山东省食品药品检验研究院 2021-10-15 CN disclosed
CN-107043386-A The preparation method of the geranyl p-benzoquinone derivative of 2 methoxyl group 5 and Scabellone C 西北大学 2017-08-15 CN disclosed
CN-107032974-A The preparation method of the geranyl p-benzoquinone derivative of 2 methoxyl group 5 and Scabellone A 西北大学 2017-08-11 CN disclosed
CN-107032973-A The preparation method of the geranyl p-benzoquinone derivative of 2 methoxyl group 5 and Scabellone B 西北大学 2017-08-11 CN disclosed
EP-2616056-A1 TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS Neuroquest Inc. (CA) 2013-07-24 EP disclosed
WO-2012034232-A1 TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS NEUROQUEST INC. (CA) 2012-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230406834-A1 PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS TTPA, ESD, CDC73 TRPV1 736/4885PPARG 1044/4885PPARA 1291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.